{"id":2017,"date":"2020-06-02T21:15:24","date_gmt":"2020-06-03T01:15:24","guid":{"rendered":"https:\/\/nebula.org\/blog\/?p=2017"},"modified":"2021-01-27T01:56:02","modified_gmt":"2021-01-27T06:56:02","slug":"genetics-her2-like-breast-cancer-zhang-2020","status":"publish","type":"post","link":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/","title":{"rendered":"HER2-enriched-like breast cancer  (Zhang, 2020)"},"content":{"rendered":"\n<p><strong>STUDY TITLE:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41588-020-0609-2\">Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses<\/a><\/p>\n\n\n\n<p><strong>SUMMARY:<\/strong> Discovery of novel genetic variants associated with HER2-enriched-like breast cancer.<\/p>\n\n\n\n<p><strong>OVERVIEW:<\/strong> Breasts are complex structures with multiple cell types which can give rise to multiple types of cancer. Breast cancers are classified by what&nbsp;<em>receptors<\/em>&nbsp;cancer cells have on the outside. This classification is helpful for predicting outcomes and effective treatments. Breast cancers that use the human epidermal growth factor 2 receptor (HER2+) make up 15-30% of all breast cancers. HER2+ breast cancers are historically associated with poor prognosis and an increased recurrence, but there are now new drugs that specifically target the HER2 receptor and improve survival.&nbsp;HER2-enriched-like cancers have the HER2 receptor but do not have other hormone&nbsp;<em>receptors<\/em>&nbsp;like&nbsp;<em>receptors<\/em>&nbsp;for estrogen or progesterone. This genome-wide association study examined nearly 266,000 individuals of European ancestry to identify genetic variants associated with different breast cancer types, including HER2-enriched-like cancers. In total, the researchers identified 330 genomic regions associated with breast cancer types and used them to calculate polygenic scores.<\/p>\n\n\n\n<p><strong>DID YOU KNOW?<\/strong> Modern therapies are able to specifically target cells that express HER2. This has dramatically increased the survival rate for patients with HER2+ breast cancer. <a href=\"https:\/\/ww5.komen.org\/KomenPerspectives\/Komen-Perspectives---Progress-in-treating-HER2\/neu-positive-breast-cancers-(December-2013).html\" target=\"_blank\" rel=\"noreferrer noopener\">[SOURCE]<\/a><\/p>\n\n\n\n<p><strong>SAMPLE RESULTS:<\/strong> Learn more about the&nbsp;<a href=\"https:\/\/nebula.org\/blog\/nebula-library-unlocking-genetic-research\/\">Nebula Research Library<\/a>. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/nebula.org\/whole-genome-sequencing\/\"><img decoding=\"async\" width=\"1024\" height=\"375\" src=\"http:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics-1024x375.png\" alt=\"her2-like breast cancer sample results\" class=\"wp-image-1066\" srcset=\"https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics-1024x375.png 1024w, https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics-300x110.png 300w, https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics-768x281.png 768w, https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics-1536x562.png 1536w, https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/01\/Nebula-personalized-results-genomics.png 924w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p><strong>HER2-ENRICHED BREAST CANCER-ASSOCIATED VARIANTS:<\/strong> rs9712235, rs4602255, rs188092014, rs13256025, rs13277568, rs11652463, rs495367, rs7924772, rs78378222, rs206435, rs17215231, rs612683, rs616488, rs7513707, rs12406858, rs637868, rs11249433, rs111458676, rs11205303, rs12091730, rs2992756, rs35383942, rs6686987, rs7514172, rs2785646, rs2576261, rs11118563, rs72755295, rs4233486, rs114282204, rs707475, rs2151842, rs78425380, rs6746250, rs17625845, rs10164550, rs10179592, rs17726078, rs1550622, rs2356656, rs6743383, rs10197246, rs4442975, rs11693806, rs3791977, rs4676356, rs6725517, rs12472404, rs4322799, rs1036759, rs9882792, rs552647, rs112476261, rs17838698, rs56387622, rs6762558, rs2886671, rs9825432, rs13066793, rs639355, rs62331150, rs56039025, rs13147907, rs10012017, rs17014016, rs17157372, rs335160, rs1428387, rs10069690, rs6860806, rs62329727, rs1432679, rs17611291, rs10074269, rs6864691, rs4868701, rs116095464, rs187108781, rs4613718, rs10941679, rs17343002, rs889310, rs16886165, rs76250845, rs11949391, rs113778879, rs3010266, rs157557, rs418053, rs2121348, rs6913578, rs60954078, rs851984, rs6904031, rs910416, rs3819405, rs9364472, rs6940159, rs12211970, rs9358466, rs34196306, rs111342015, rs73754909, rs71559437, rs7800548, rs12706954, rs68056147, rs62485509, rs7971, rs289997, rs74765302, rs13244925, rs17268829, rs4439053, rs111963714, rs62517052, rs12546444, rs13267382, rs62526620, rs35542655, rs12541094, rs7842619, rs12550713, rs10096351, rs1016578, rs7830152, rs66823261, rs1028016, rs310295, rs9693444, rs13365225, rs1511243, rs72658084, rs1533366, rs10816625, rs13294895, rs7848334, rs630965, rs1895062, rs3861871, rs17694493, rs4880038, rs10975870, rs10120432, rs10885405, rs12250948, rs45631580, rs45631563, rs10796139, rs7072776, rs10764337, rs2384736, rs10995201, rs6479868, rs111833376, rs719338, rs4980029, rs7125780, rs610437, rs625145, rs7121616, rs7939702, rs11822830, rs10832963, rs4980386, rs4472923, rs7394715, rs10838267, rs77047825, rs12287832, rs10896047, rs35039974, rs661204, rs78540526, rs6597981, rs2454399, rs12422552, rs788458, rs7297051, rs2277339, rs17356907, rs56404467, rs11571833, rs9315973, rs12870942, rs2181965, rs4983544, rs34914085, rs2253012, rs2588809, rs11624333, rs941764, rs78440108, rs144767203, rs187010898, rs4774565, rs8042593, rs35874463, rs8035987, rs2290202, rs34872983, rs75753503, rs11076805, rs35668161, rs4784227, rs55872725, rs6499648, rs7184573, rs28539243, rs12709163, rs7500067, rs9931038, rs12449271, rs79461387, rs150537328, rs11296, rs17881320, rs149370081, rs2787486, rs745570, rs16976596, rs11665269, rs1111207, rs527616, rs8092192, rs72931898, rs9954058, rs9952980, rs117922601, rs56069439, rs10164323, rs56681946, rs4399645, rs1172821, rs1154723, rs6030585, rs13039563, rs16991615, rs2822999, rs2823130, rs2403907, rs4818836, rs9798754, rs17879961, rs5997390, rs34134147, rs132289, rs5750715, rs9611990, rs112855987, rs28512361<\/p>\n\n\n\n<p><strong>ADDITIONAL RESOURCES:<\/strong><br><a rel=\"noreferrer noopener\" href=\"https:\/\/www.youtube.com\/watch?v=boIO9i2HvuM\" target=\"_blank\">HER2 positive breast cancer: everything you must know (Video)<\/a><br><a rel=\"noreferrer noopener\" href=\"https:\/\/www.breastcancer.org\/symptoms\/diagnosis\/her2\" target=\"_blank\">HER2 status<\/a><\/p>\n\n\n\n<p><strong>YOU MAY ALSO BE INTERESTED IN:<br><\/strong><a href=\"https:\/\/nebula.org\/blog\/genetics-luminal-a-breast-cancer-zhang-2020\/\">Luminal A-like breast cancer (Zhang, 2020)<\/a><br><a href=\"https:\/\/nebula.org\/blog\/genetics-luminal-b-her2-negative-like-breast-cancer-zhang-2020\/\">Luminal B\/HER2-negative-like breast cancer (Zhang, 2020)<\/a><br><a href=\"https:\/\/nebula.org\/blog\/genetics-luminal-b-like-breast-cancer-zhang-2020\/\">Luminal B-like breast cancer (Zhang, 2020)<\/a><br><a href=\"https:\/\/nebula.org\/blog\/genetics-triple-negative-breast-cancer-zhang-2020\/\">Triple-negative breast cancer (Zhang, 2020)<\/a><br><a href=\"https:\/\/nebula.org\/blog\/breast-cancer-shu-2020\/\">Breast cancer (Shu, 2020)<\/a><\/p>\n\n\n\n<p><strong>WEEKLY UPDATE:<\/strong> June 2, 2020<\/p>\n\n\n\n<p><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STUDY TITLE: Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses SUMMARY: Discovery of novel genetic variants associated with HER2-enriched-like breast cancer. OVERVIEW: Breasts are complex structures with multiple cell types which can give &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"ast-button\" href=\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\"> <span class=\"screen-reader-text\">HER2-enriched-like breast cancer  (Zhang, 2020)<\/span> Read More \u00bb<\/a><\/p>\n","protected":false},"author":12,"featured_media":2018,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":""},"categories":[50],"tags":[],"class_list":["post-2017","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reports"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.13 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The genetics of HER2-enriched-like breast cancer (Zhang, 2020)<\/title>\n<meta name=\"description\" content=\"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The genetics of HER2-enriched-like breast cancer (Zhang, 2020)\" \/>\n<meta property=\"og:description\" content=\"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Nebula Genomics Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/nebulagenomics\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-03T01:15:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-27T06:56:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/06\/jan-kopriva-aQCClWOS9dY-unsplash-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"924\" \/>\n\t<meta property=\"og:image:height\" content=\"924\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Garrett Dunlap, B.S.\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@nebulagenomics\" \/>\n<meta name=\"twitter:site\" content=\"@nebulagenomics\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Garrett Dunlap, B.S.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\"},\"author\":{\"name\":\"Garrett Dunlap, B.S.\",\"@id\":\"https:\/\/nebula.org\/blog\/#\/schema\/person\/b7bd0a490f115d1d931c33eed922af4e\"},\"headline\":\"HER2-enriched-like breast cancer (Zhang, 2020)\",\"datePublished\":\"2020-06-03T01:15:24+00:00\",\"dateModified\":\"2021-01-27T06:56:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\"},\"wordCount\":530,\"publisher\":{\"@id\":\"https:\/\/nebula.org\/blog\/#organization\"},\"articleSection\":[\"Reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\",\"url\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\",\"name\":\"The genetics of HER2-enriched-like breast cancer (Zhang, 2020)\",\"isPartOf\":{\"@id\":\"https:\/\/nebula.org\/blog\/#website\"},\"datePublished\":\"2020-06-03T01:15:24+00:00\",\"dateModified\":\"2021-01-27T06:56:02+00:00\",\"description\":\"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.\",\"breadcrumb\":{\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nebula.org\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HER2-enriched-like breast cancer (Zhang, 2020)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nebula.org\/blog\/#website\",\"url\":\"https:\/\/nebula.org\/blog\/\",\"name\":\"Nebula Genomics Blog\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/nebula.org\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nebula.org\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/nebula.org\/blog\/#organization\",\"name\":\"Nebula Genomics\",\"url\":\"https:\/\/nebula.org\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nebula.org\/blog\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nebula Genomics\"},\"image\":{\"@id\":\"https:\/\/nebula.org\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/nebulagenomics\",\"https:\/\/twitter.com\/nebulagenomics\",\"https:\/\/www.instagram.com\/nebulagenomics\/\",\"https:\/\/www.linkedin.com\/company\/nebula-genomics\/\",\"https:\/\/en.wikipedia.org\/wiki\/Nebula_Genomics\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/nebula.org\/blog\/#\/schema\/person\/b7bd0a490f115d1d931c33eed922af4e\",\"name\":\"Garrett Dunlap, B.S.\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nebula.org\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/32fb6e0dbc7e0bac908b0f23ea6ed5ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/32fb6e0dbc7e0bac908b0f23ea6ed5ec?s=96&d=mm&r=g\",\"caption\":\"Garrett Dunlap, B.S.\"},\"description\":\"Garrett Dunlap earned a B.S. in Biology from Case Western Reserve University with a minor in Political Science. He earned an M.S. and is currently a Ph.D. Candidate in the Biological and Biomedical Sciences (BBS) Ph.D. program at Harvard University.\u00a0He has experience in science policy as an intern at the Science and Innovation Network where he assisted in the science diplomacy functions of the British Consulate-General and as a research associate at TScan Therapeutics. He is also interested in science communication and writing. You can read more about Garrett's experience and publications on LinkedIn and ORCID.\",\"sameAs\":[\"https:\/\/nebula.org\/whole-genome-sequencing\/\"],\"url\":\"https:\/\/nebula.org\/blog\/author\/garrett-dunlap\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The genetics of HER2-enriched-like breast cancer (Zhang, 2020)","description":"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/","og_locale":"en_US","og_type":"article","og_title":"The genetics of HER2-enriched-like breast cancer (Zhang, 2020)","og_description":"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.","og_url":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/","og_site_name":"Nebula Genomics Blog","article_publisher":"https:\/\/facebook.com\/nebulagenomics","article_published_time":"2020-06-03T01:15:24+00:00","article_modified_time":"2021-01-27T06:56:02+00:00","og_image":[{"width":924,"height":924,"url":"https:\/\/nebula.org\/blog\/wp-content\/uploads\/2020\/06\/jan-kopriva-aQCClWOS9dY-unsplash-scaled.jpg","type":"image\/jpeg"}],"author":"Garrett Dunlap, B.S.","twitter_card":"summary_large_image","twitter_creator":"@nebulagenomics","twitter_site":"@nebulagenomics","twitter_misc":{"Written by":"Garrett Dunlap, B.S.","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#article","isPartOf":{"@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/"},"author":{"name":"Garrett Dunlap, B.S.","@id":"https:\/\/nebula.org\/blog\/#\/schema\/person\/b7bd0a490f115d1d931c33eed922af4e"},"headline":"HER2-enriched-like breast cancer (Zhang, 2020)","datePublished":"2020-06-03T01:15:24+00:00","dateModified":"2021-01-27T06:56:02+00:00","mainEntityOfPage":{"@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/"},"wordCount":530,"publisher":{"@id":"https:\/\/nebula.org\/blog\/#organization"},"articleSection":["Reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/","url":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/","name":"The genetics of HER2-enriched-like breast cancer (Zhang, 2020)","isPartOf":{"@id":"https:\/\/nebula.org\/blog\/#website"},"datePublished":"2020-06-03T01:15:24+00:00","dateModified":"2021-01-27T06:56:02+00:00","description":"Upload your DNA data, explore genetic variants linked to HER2-enriched-like breast cancer (Zhang, 2020), and discover your polygenic score.","breadcrumb":{"@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nebula.org\/blog\/genetics-her2-like-breast-cancer-zhang-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nebula.org\/blog\/"},{"@type":"ListItem","position":2,"name":"HER2-enriched-like breast cancer (Zhang, 2020)"}]},{"@type":"WebSite","@id":"https:\/\/nebula.org\/blog\/#website","url":"https:\/\/nebula.org\/blog\/","name":"Nebula Genomics Blog","description":"","publisher":{"@id":"https:\/\/nebula.org\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nebula.org\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nebula.org\/blog\/#organization","name":"Nebula Genomics","url":"https:\/\/nebula.org\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nebula.org\/blog\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nebula Genomics"},"image":{"@id":"https:\/\/nebula.org\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/nebulagenomics","https:\/\/twitter.com\/nebulagenomics","https:\/\/www.instagram.com\/nebulagenomics\/","https:\/\/www.linkedin.com\/company\/nebula-genomics\/","https:\/\/en.wikipedia.org\/wiki\/Nebula_Genomics"]},{"@type":"Person","@id":"https:\/\/nebula.org\/blog\/#\/schema\/person\/b7bd0a490f115d1d931c33eed922af4e","name":"Garrett Dunlap, B.S.","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nebula.org\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/32fb6e0dbc7e0bac908b0f23ea6ed5ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32fb6e0dbc7e0bac908b0f23ea6ed5ec?s=96&d=mm&r=g","caption":"Garrett Dunlap, B.S."},"description":"Garrett Dunlap earned a B.S. in Biology from Case Western Reserve University with a minor in Political Science. He earned an M.S. and is currently a Ph.D. Candidate in the Biological and Biomedical Sciences (BBS) Ph.D. program at Harvard University.\u00a0He has experience in science policy as an intern at the Science and Innovation Network where he assisted in the science diplomacy functions of the British Consulate-General and as a research associate at TScan Therapeutics. He is also interested in science communication and writing. You can read more about Garrett's experience and publications on LinkedIn and ORCID.","sameAs":["https:\/\/nebula.org\/whole-genome-sequencing\/"],"url":"https:\/\/nebula.org\/blog\/author\/garrett-dunlap\/"}]}},"_links":{"self":[{"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/posts\/2017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/comments?post=2017"}],"version-history":[{"count":0,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/posts\/2017\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/media\/2018"}],"wp:attachment":[{"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/media?parent=2017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/categories?post=2017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nebula.org\/blog\/wp-json\/wp\/v2\/tags?post=2017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}